Kwality Pharmaceuticals Ltd Share Price

Pharmaceuticals

NSE: KPL Small Cap ISIN: INE552U01010

As on 13 June 2026 at 02:25 IST

₹2,453.10

+ 90.70

(3.84%)

Sell Buy

Over 1 Month

38.49%

Over 6 Months

None%

Over 1 Year

None%

Over 3 Years

None%

Kwality Pharmaceuticals Ltd Summary

Close ₹2,362.40

Open ₹2,544

High ₹2,548.90

Low ₹2,325

Volume 46,724

Net Turnover (in Cr) ₹11.46

52Wk High ₹2,600

52Wk Low ₹1,561

52Wk High / Low

1,561

2,600

Kwality Pharmaceuticals Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹2,451.27

EPS (TTM) 65.50

Book Value (BV) 320.52

Div. Yield -

P/E (TTM) 36.56

Price/Book Value 7.40

Delivery % 38.64 %

Face Value 10

Key Ratios

PE Ratio 22.61

PB Ratio 3.40

EV to Sales 2.70

PEG Ratio 0.34

ROA 10.54

ROE 16.27

Debt-Equity 0.43

Net Profit Margin 10.78

Operating Profit Margin 22.25

Kwality Pharmaceuticals Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	372.12	309	253.97	459.70	263.60
Total Expenses	317.98	270.80	211.87	298.13	242.33
Profit Before Tax	54.14	31.10	25.57	161.57	21.27
Profit After Tax	39.80	23.62	19.28	119.94	14.89
Operating Profit After Depreciation	64.02	48.58	48.12	164.48	23.94

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	145.69	139.05	120.50	91.73	56.53
Total Non Current Assets	163.49	151.52	146.43	112.77	60.36
Total Current Assets	283.78	242.69	207.20	227.82	105.90
Total Assets	447.27	394.21	353.63	340.59	166.26
Total Shareholder's Fund	264.05	224.21	200.52	181.14	61.15

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	52.72	42.98	41.38	60.60	26.71
Net Cash Used In Investing Activities	-28.52	-26.40	-48.44	-62.93	-23.20
Net Cash Used In Financing Activities	-14.44	-17.40	0.99	5.66	0.77

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	372.12	309	253.94	459.64	263.09
Total Expenses	317.89	270.44	211.65	297.97	241.29
Profit Before Tax	54.23	31.47	25.76	161.67	21.80
Profit After Tax	39.89	23.98	19.47	120.05	15.41
Operating Profit After Depreciation	64.10	48.95	48.31	164.59	24.41

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	144.47	138.18	119.57	90.77	55.52
Total Non Current Assets	165.82	154.19	149.06	115.36	62.90
Total Current Assets	284.90	243.38	207.52	227.32	105.88
Total Assets	450.72	397.57	356.58	342.68	168.78
Total Shareholder's Fund	265.84	225.94	202.03	182.56	62.51

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	52.77	43.35	42.19	59.24	26.36
Net Cash Used In Investing Activities	-28.13	-26.40	-48.44	-62.98	-23.20
Net Cash Used In Financing Activities	-14.44	-17.40	0.99	5.66	0.83

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	157.11	123.44	111.05	111.48	115.68
Total Expenses	118.36	93.49	85.70	87.31	89.78
Profit Before Tax	31.66	22.35	18.45	17.03	19.09
Profit After Tax	25.31	16	14.12	11.92	14.48
Operating Profit after Depreciation	39.81	30.48	26.25	24.55	26.67

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	156.82	123.44	111.31	111.48	115.68
Total Expenses	118.08	93.49	85.96	87.29	89.78
Profit Before Tax	31.65	22.35	18.45	17.05	19.10
Profit After Tax	25.29	16.01	14.12	11.93	14.50
Operating Profit after Depreciation	39.80	30.48	26.25	24.57	26.67

Kwality Pharmaceuticals Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 2,275.30

S2 2,188.20

S3 2,051.40

Pivot 2,412.10

R1 2,499.20

R2 2,636

R3 2,723.10

Moving Average

20 SMA 2,177.43

50 SMA -

100 SMA -

200 SMA -

Kwality Pharmaceuticals Ltd Corporate Actions

No available data

AGM Date: 30 Sep 2021

AGM 30/09/2021 Please find attached herewith copy of notice of 38TH AGM to be held on Thursday 30th September, 2021 at the Regd Office of the company situated at VILLAGE NAGKALAN, MAJITHA ROAD, AMRITSAR, PUNJAB-143601. In terms of regulation 30 read with Part A of Schedule III of SEBI (Listing obligations & Disclosure Requirements) Regulations, 2015, enclosed are the proceedings of the 38th Annual General Meeting (AGM) of the Company held on Thursday, 30th September, 2021 at 11:30 A.M. at the registered Office of the Company situated at 'VILLAGE NAGKALAN, MAJITHA ROAD, AMRITSAR - 143601'. (As Per BSE announcement Dated on 01.10.2021)

AGM Date: 30 Sep 2022

AGM 30/09/2022 The following matters were decided by the board: 1. The Board of directors of the company have considered and approved the Report of Board of Directors under Section 134 of the Companies Act, 2013 for the year ended 31st March, 2022. 2.The Board of directors of the company have considered and approved the Notice of 39th Annual General Meeting of the Company. 3. Date, Time and Place of the 39thAnnual General Meeting has been fixed. 4. Dates of Book Closure for the purpose of 39th Annual General Meeting has been fixed and approved by the Board. 5. Considered and approved E-voting facility: E-voting facility for the Shareholders shall commence from 27th September, 2022 at 9:00 A.M. to 29th September, 2022, 5:00 P.M. 6. Considered and approved Mr. Rishi Mittal, Practicing Company Secretary as Scrutinizer for 39th Annual General Meeting to held on 30th September, 2022. (As Per BSE Announcement Dated on 06.09.2022) In terms of regulation 30 read with Part A of Schedule III of SEBI (Listing obligations & Disclosure Requirements) Regulations, 2015, enclosed are the proceedings of the 39th Annual General Meeting (AGM) of the Company held on Friday, 30th September, 2022 at 11:30 A.M. at the registered Office of the Company situated at 'VILLAGE NAGKALAN, MAJITHA ROAD, AMRITSAR - 143601'. (As Per BSE Announcement Dated 01.10.2022)

AGM Date: 30 Sep 2023

AGM 30/09/2023 Outcome of Board meeting held on September 06, 2023 (As Per BSE Announcement Dated on 06.09.2023) Disclosure of E Voting Results and Scrutinizer''s Report of 40th AGM (As per BSE Announcement Dated on 04/10/2023)

AGM Date: 24 Sep 2024

AGM 24/09/2024 NOTICE OF AGM ENCLOSED (As Per BSE Announcement Dated on: 31/08/2024) Proceedings of AGM (As Per BSE Announcement Dated on: 24/09/2024) Scrutinizer Report (As Per BSE Announcement Dated on: 26/09/2024)

AGM Date: 09 Sep 2025

AGM 09/09/2025 This is to inform you under Regulation 30 and any other regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 that the Board of Directors of the Company at its meeting held today i.e. Saturday, August 16, 2025 inter-alia has taken the following decisions:- 1. The Board of Directors of the Company have considered and approved the Report of Board of Directors for the financial year ended as on March 31, 2025 under section 134 of the Companies Act, 2013. 2. The Board of Directors of the Company have considered and approved the Notice of 42nd Annual General Meeting of the Company. 3. The Board has approved the day, date, time and calendar of events and Notice of 42nd Annual General Meeting of the company to be held on Tuesday 09th September, 2025 at 12:00 noon, through Video Conferencing ('VC')/Other Audio Visual Means ('OAVM'). * OTHER DETAILS AS PER ATTACHMENT Read less.. (As Per BSE Announcement Dated on 16.08.2025) Proceedings of 42nd AGM are enclosed herewith (As Per Bse Announcement dated on 09/09/2025)

Kwality Pharmaceuticals Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceutical Industries Ltd	₹1,794.30	₹4,30,512.67
Divis Laboratories Ltd	₹6,651.25	₹1,76,569.79
Torrent Pharmaceuticals Ltd	₹4,570	₹1,54,669.57
Cipla Ltd	₹1,383	₹1,11,725.01
Zydus Lifesciences Ltd	₹1,105.65	₹1,11,254.26

Kwality Pharmaceuticals Ltd Top Mutal Funds Invested

Fund Name	AUM
Bandhan BSE Healthcare Index Fund	0.07%

Kwality Pharmaceuticals Ltd News

Kwality Pharma surges on strong Q4 numbers; PAT jumps 75%

Kwality Pharmaceuticals rose 9.06% to Rs 2,000 after the company reported strong earnings growth for the quarter ended March 2026.

19 May 2026, 03:01 pm

Kwality Pharmaceuticals to conduct board meeting

On 19 May 2026

09 May 2026, 11:18 am

Kwality Pharmaceuticals receives upgrade in credit ratings from ICRA

08 May 2026, 12:44 pm

Kwality Pharmaceuticals to announce Quarterly Result

On 12 February 2026

02 Feb 2026, 05:47 pm

Kwality Pharmaceuticals to table results

On 13 November 2025

06 Nov 2025, 12:48 pm

Kwality Pharmaceuticals Ltd Stock Analysis

Annual revenue for Kwality Pharmaceuticals Ltd increased by 20.43% to ₹372.12 crore in FY 2025 from ₹309 crore in FY 2024.
Annual Net Profit for Kwality Pharmaceuticals Ltd increased by 66.32% to ₹39.89 crore in FY 2025 from ₹23.98 crore in FY 2024.
Promoter Shareholding in Kwality Pharmaceuticals Ltd increased by 0.07% in the most recent quarter, from 54.83% in December 2025 to 54.87% in March 2026.
Kwality Pharmaceuticals Ltd delivered a 1-year return of 0% compared to the Nifty 50, which provided a return of -7.87% as of the last trading session.
Kwality Pharmaceuticals Ltd share price moved up by 3.84% from its previous close of INR ₹2,362.40. The latest Kwality Pharmaceuticals Ltd share price is INR ₹2,453.10.
Kwality Pharmaceuticals Ltd share price today has been at a low of 2,380 and a high of 2,487. Over the past 52 weeks, the Kwality Pharmaceuticals Ltd share price has seen a low of 1,561 and a high of 2,600.